ArticleOsteoarthritis and cartilage open2025
Explanatory factors for the survival benefit among hip and knee arthroplasty patients with osteoarthritis.
Article in Osteoarthritis and cartilage open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Studies have shown that osteoarthritis patients who underwent a primary total hip or knee arthroplasty (THA/TKA) experience better survival than the general population, yet there is limited evidence explaining this counter-intuitive difference. We investigated whether this better survival is also present in the Netherlands and to what extent it could be explained by a patient selection effect, whereby patients with more favorable health and socioeconomic status (SES) are more likely to receive THA/TKA. Design: In this registry-based study, we compared the survival, health and SES of THA/TKA osteoarthritis patients to those of the general Dutch population. The patient cohort included 224,785 THA and 198,691 TKA patients who underwent an arthroplasty between 2010-2020. The proportions of the survival differences explained by better health (as measured by the EQ-5D) and SES (postcode-level) were estimated using spline-based survival models and Dutch lifetables. Results: The eleven-year survival of THA and TKA patients were 8.7% and 8.1% better than the general population. Although health and SES predicted individual survival, they explained only ≈7% of the survival benefit. Conclusions: Our study confirmed that Dutch osteoarthritis THA/TKA patients experience better survival than the general population, but raises important questions as to the explanation. A more favorable health status and/or SES did not explain most of the survival benefit. This may be partly due to limitations of the available measures of health and SES in our study, but also leaves other explanations (e.g. barriers to receive access to care, lifestyle changes) open for further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.